Ironwood Investment Counsel’s AbbVie ABBV Stock Holding History

Ironwood Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.29M	Sell	9,119 -156	-2%	-$33.6K	0.3%	81
2026 Q1	$2.02M	Sell	9,275 -118	-1%	-$26.2K	0.29%	84
2025 Q4	$2.15M	Sell	9,393 -2,105	-18%	-$480K	0.3%	79
2025 Q3	$2.66M	Sell	11,498 -472	-4%	-$96.1K	0.39%	67
2025 Q2	$2.22M	Buy	11,970 +2,030	+20%	+$377K	0.34%	70
2025 Q1	$2.08M	Buy	9,940 +84	+0.9%	+$16.3K	0.36%	72
2024 Q4	$1.75M	Sell	9,856 -41	-0.4%	-$7.54K	0.3%	77
2024 Q3	$1.95M	Buy	9,897 +66	+0.7%	+$12.3K	0.33%	73
2024 Q2	$1.69M	Sell	9,831 -227	-2%	-$37.6K	0.3%	81
2024 Q1	$1.83M	Sell	10,058 -357	-3%	-$61.5K	0.32%	79
2023 Q4	$1.61M	Sell	10,415 -238	-2%	-$34.7K	0.3%	83
2023 Q3	$1.59M	Buy	10,653 +4,320	+68%	+$634K	0.33%	78
2023 Q2	$853K	Sell	6,333 -932	-13%	-$137K	0.19%	101
2023 Q1	$1.16M	Sell	7,265 -369	-5%	-$56.4K	0.28%	84
2022 Q4	$1.23M	Sell	7,634 -219	-3%	-$33.6K	0.3%	84
2022 Q3	$1.05M	Sell	7,853 -659	-8%	-$94.6K	0.3%	82
2022 Q2	$1.3M	Sell	8,512 -999	-11%	-$153K	0.37%	76
2022 Q1	$1.54M	Sell	9,511 -179	-2%	-$26K	0.38%	70
2021 Q4	$1.31M	Sell	9,690 -39	-0.4%	-$4.61K	0.3%	75
2021 Q3	$1.05M	Buy	9,729 +277	+3%	+$31.7K	0.27%	79
2021 Q2	$1.06M	Sell	9,452 -70	-0.7%	-$7.88K	0.28%	80
2021 Q1	$1.03M	Sell	9,522 -3,900	-29%	-$417K	0.3%	74
2020 Q4	$1.44M	Buy	13,422 +2,666	+25%	+$256K	0.33%	71
2020 Q3	$942K	Sell	10,756 -105	-1%	-$9.88K	0.25%	87
2020 Q2	$1.07M	Buy	10,861 +907	+9%	+$79.9K	0.33%	70
2020 Q1	$758K	Sell	9,954 -20	-0.2%	-$1.7K	0.3%	80
2019 Q4	$883K	Buy	9,974 +773	+8%	+$64.2K	0.3%	76
2019 Q3	$696K	Buy	9,201 +30	+0.3%	+$2.06K	0.26%	82
2019 Q2	$666K	Buy	9,171 +675	+8%	+$53.1K	0.25%	79
2019 Q1	$684K	Buy	8,496 +330	+4%	+$27K	0.27%	79
2018 Q4	$752K	Buy	8,166 +451	+6%	+$39.7K	0.33%	74
2018 Q3	$729K	Sell	7,715 -60	-0.8%	-$5.69K	0.28%	80
2018 Q2	$720K	Sell	7,775 -139	-2%	-$13.6K	0.31%	75
2018 Q1	$749K	Sell	7,914 -1,147	-13%	-$126K	0.33%	68
2017 Q4	$876K	Buy	9,061 +216	+2%	+$20.4K	0.32%	67
2017 Q3	$786K	Sell	8,845 -9,998	-53%	-$761K	0.32%	65
2017 Q2	$1.37M	Sell	18,843 -97	-0.5%	-$6.52K	0.52%	50
2017 Q1	$1.23M	Buy	18,940 +601	+3%	+$37.8K	0.52%	54
2016 Q4	$1.15M	Buy	18,339 +169	+0.9%	+$10.3K	0.51%	54
2016 Q3	$1.15M	Buy	18,170 +495	+3%	+$32K	0.54%	54
2016 Q2	$1.09M	Sell	17,675 -83	-0.5%	-$5.06K	0.64%	51
2016 Q1	$1.01M	Buy	17,758 +83	+0.5%	+$4.63K	0.53%	59
2015 Q4	$1.05M	Sell	17,675 -100	-0.6%	-$5.76K	0.6%	52
2015 Q3	$967K	Hold	17,775	–	–	0.52%	56
2015 Q2	$1.19M	Hold	17,775	–	–	0.61%	49
2015 Q1	$1.04M	Hold	17,775	–	–	0.53%	52
2014 Q4	$1.16M	Sell	17,775 -100	-0.6%	-$6.3K	0.59%	49
2014 Q3	$1.03M	Sell	17,875 -200	-1%	-$11.1K	0.55%	52
2014 Q2	$1.02M	Hold	18,075	–	–	0.53%	52
2014 Q1	$929K	Hold	18,075	–	–	0.51%	56
2013 Q4	$955K	Hold	18,075	–	–	0.54%	54
2013 Q3	$808K	Sell	18,075 -600	-3%	-$26.6K	0.53%	54
2013 Q2	$772K	Buy	+18,675	New	+$817K	0.5%	55

Other funds holding ABBV

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Ironwood Investment Counsel's ABBV Position: Q2 2026 in Review

Ironwood Investment Counsel reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $33.6K and leaving 9,119 shares worth $2.29M. The position accounts for 0.3% of the portfolio, ranked #81.

Ironwood Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.66M in Q3 2025. 2,700 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ironwood Investment Counsel held 9,119 shares of AbbVie worth $2.29M as of Q2 2026.
Ironwood Investment Counsel sold 156 AbbVie shares in Q2 2026, an estimated $33.6K.
AbbVie made up 0.3% of Ironwood Investment Counsel's portfolio in Q2 2026, its #81 holding.
Ironwood Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Ironwood Investment Counsel's AbbVie position peaked at $2.66M in Q3 2025.
2,700 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.